ProcellaRX Calls on Life Sciences to Reinvent Digital Validation: A Vision for 2030
37 practitioners. 5 pharma companies. One shared conviction: legacy computerized system validation no longer serves the industry it was built to protect ALEXANDRIA, VA, UNITED STATES, March 26, 2026 /EINPresswire.com/ -- ProcellaRX, LLC today released "The Reinvention Lab: A Vision for the Future of Digital Validation 2030," a collaborative white paper representing the collective output of 37 pharmaceutical industry practitioners convened at the North Carolina Biotechnology Center in Research …